| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-07 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |